Global Chronic Obstructive Pulmonary Disorder (COPD) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 147650
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production.

Scope of the Report:

This report focuses on the Chronic Obstructive Pulmonary Disorder (COPD) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Chronic Obstructive Pulmonary Disorder (COPD) is expected to grow at a CAGR of roughly 4.1% over the next five years, will reach 14400 million US$ in 2023, from 11300 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Abbott

AstraZeneca

GSK

Roche

Novartis

Merck

Pfizer

Dr. Reddy’s

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Inhaled Steroids

Combination Inhalers

Oral Steroids

Market Segment by Applications, can be divided into

Hospital

Clinic

There are 15 Chapters to deeply display the global Chronic Obstructive Pulmonary Disorder (COPD) market.

Chapter 1, to describe Chronic Obstructive Pulmonary Disorder (COPD) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Chronic Obstructive Pulmonary Disorder (COPD), with sales, revenue, and price of Chronic Obstructive Pulmonary Disorder (COPD), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Chronic Obstructive Pulmonary Disorder (COPD), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Chronic Obstructive Pulmonary Disorder (COPD) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Chronic Obstructive Pulmonary Disorder (COPD) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Chronic Obstructive Pulmonary Disorder (COPD) Introduction

1.2 Market Analysis by Type

1.2.1 Inhaled Steroids

1.2.2 Combination Inhalers

1.2.3 Oral Steroids

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott

2.1.1 Business Overview

2.1.2 Chronic Obstructive Pulmonary Disorder (COPD) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca

2.2.1 Business Overview

2.2.2 Chronic Obstructive Pulmonary Disorder (COPD) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GSK

2.3.1 Business Overview

2.3.2 Chronic Obstructive Pulmonary Disorder (COPD) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GSK Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Roche

2.4.1 Business Overview

2.4.2 Chronic Obstructive Pulmonary Disorder (COPD) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Roche Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novartis

2.5.1 Business Overview

2.5.2 Chronic Obstructive Pulmonary Disorder (COPD) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novartis Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Merck

2.6.1 Business Overview

2.6.2 Chronic Obstructive Pulmonary Disorder (COPD) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Merck Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Chronic Obstructive Pulmonary Disorder (COPD) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Dr. Reddy’s

2.8.1 Business Overview

2.8.2 Chronic Obstructive Pulmonary Disorder (COPD) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Dr. Reddy’s Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Chronic Obstructive Pulmonary Disorder (COPD) Manufacturer Market Share in 2017

3.3.2 Top 6 Chronic Obstructive Pulmonary Disorder (COPD) Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis by Regions

4.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales, Revenue and Market Share by Regions

4.1.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Regions (2013-2018)

4.1.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Regions (2013-2018)

4.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

4.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

4.5 South America Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

5 North America Chronic Obstructive Pulmonary Disorder (COPD) by Countries

5.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Sales, Revenue and Market Share by Countries

5.1.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Countries (2013-2018)

5.1.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Countries (2013-2018)

5.2 United States Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

5.3 Canada Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

5.4 Mexico Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

6 Europe Chronic Obstructive Pulmonary Disorder (COPD) by Countries

6.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Sales, Revenue and Market Share by Countries

6.1.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Countries (2013-2018)

6.2 Germany Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

6.3 UK Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

6.4 France Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

6.5 Russia Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

6.6 Italy Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

7 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) by Countries

7.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Countries (2013-2018)

7.2 China Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

7.3 Japan Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

7.4 Korea Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

7.5 India Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

8 South America Chronic Obstructive Pulmonary Disorder (COPD) by Countries

8.1 South America Chronic Obstructive Pulmonary Disorder (COPD) Sales, Revenue and Market Share by Countries

8.1.1 South America Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Countries (2013-2018)

8.1.2 South America Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

8.3 Argentina Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

8.4 Colombia Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

9 Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) by Countries

9.1 Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

9.3 UAE Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

9.4 Egypt Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

9.5 Nigeria Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

9.6 South Africa Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2013-2018)

10 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Segment by Type

10.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Type (2013-2018)

10.1.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Type (2013-2018)

10.2 Inhaled Steroids Sales Growth and Price

10.2.1 Global Inhaled Steroids Sales Growth (2013-2018)

10.2.2 Global Inhaled Steroids Price (2013-2018)

10.3 Combination Inhalers Sales Growth and Price

10.3.1 Global Combination Inhalers Sales Growth (2013-2018)

10.3.2 Global Combination Inhalers Price (2013-2018)

10.4 Oral Steroids Sales Growth and Price

10.4.1 Global Oral Steroids Sales Growth (2013-2018)

10.4.2 Global Oral Steroids Price (2013-2018)

11 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Segment by Application

11.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

12 Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2018-2023)

12.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales, Revenue and Growth Rate (2018-2023)

12.2 Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast by Regions (2018-2023)

12.2.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2018-2023)

12.2.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2018-2023)

12.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2018-2023)

12.2.4 South America Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2018-2023)

12.2.5 Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2018-2023)

12.3 Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast by Type (2018-2023)

12.3.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Forecast by Type (2018-2023)

12.3.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share Forecast by Type (2018-2023)

12.4 Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast by Application (2018-2023)

12.4.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Forecast by Application (2018-2023)

12.4.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Chronic Obstructive Pulmonary Disorder (COPD) Picture

Table Product Specifications of Chronic Obstructive Pulmonary Disorder (COPD)

Figure Global Sales Market Share

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery